Terms: = Lymphoma AND GNAS, RP4-543J19_4, 2778, ENSG00000087460, NESP55, NESP, GSP, POH, GNASXL, GNAS1, C20orf45, dJ309F20_1_1, SCG6, GPSA, Gnas, dJ806M20_3_3, XL2, MGC33735, XL, PHP1A, GSA, AHO, XLalphas, PHP1B AND Treatment
20535 results:
1. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
2. [Correlation Analysis of Peripheral Blood B Cell Count with Clinical Features and Prognosis in Patients Newly Diagnosed with Diffuse Large B-Cell lymphoma].
Lu T; Mi H; Zhao DD; Yang SG; Bu YW; Zhang F; Chen WM; Sun DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):458-465. PubMed ID: 38660852
[TBL] [Abstract] [Full Text] [Related]
3. [A Real-World Single-Center Study of Adult Hodgkin's lymphoma].
Wang LL; Tian L; Dong F; Yang P; Wan W; Li QH; Ma L; Gao JJ; Wang JJ; Zhao W; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):428-433. PubMed ID: 38660847
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line
Valizadeh Toosi SM; Feyzi S; Kazemi A
Korean J Gastroenterol; 2024 Apr; 83(4):150-156. PubMed ID: 38659251
[TBL] [Abstract] [Full Text] [Related]
5. Web-based cognitive rehabilitation intervention for cancer-related cognitive impairment following chemotherapy for aggressive lymphoma: protocol for a randomised pilot trial.
Gates P; Green HJ; Gough K; Dhillon H; Vardy JL; Dickinson M; Guarnera J; Krishnasamy M; Livingston PM; White V; Ugalde A; Caeyenberghs K
BMJ Open; 2024 Apr; 14(4):e081084. PubMed ID: 38653511
[TBL] [Abstract] [Full Text] [Related]
6. Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma.
Wang H; Feng J; Liu Y; Qian Z; Gao D; Ran X; Zhou H; Liu L; Wang B; Fang M; Zhou H; Huang Z; Tao S; Chen Z; Su L; Su H; Yang Y; Xie X; Wu H; Sun P; Hu G; Liang A; Li Z
Signal Transduct Target Ther; 2024 Apr; 9(1):99. PubMed ID: 38627366
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Features of Non-Hodgkin lymphoma-Associated Hemophagocytic Syndrome: a Retrospective Study.
Wu C; Liu H; Chen J
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623661
[TBL] [Abstract] [Full Text] [Related]
8. [Efficacy and safety analysis of P-GemDOx regimen and stratified prognosis in patients with early extranodal NK/T cell lymphoma].
Xing TY; Wang WT; Shen HR; Wu JZ; Yin H; Li Y; Wang L; Liang JH; Li JY; Xu W
Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):163-169. PubMed ID: 38604793
[No Abstract] [Full Text] [Related]
9. Real-World Challenges of Managing Diffuse Large B-Cell lymphoma in a Developing Country.
Iftikhar R; Ahmad U; Haider G; Mahmood H; Khan M; Masood M; Anwar N; Javed Q; Sajid N; Tariq R; Mehmod S; Haider J; Abro NA; Shahbaz S; Khokhar A; Khan ZA; Pervez H; Moosajee M; Aziz Z
JCO Glob Oncol; 2024 Apr; 10():e2300386. PubMed ID: 38603657
[TBL] [Abstract] [Full Text] [Related]
10. Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy.
Sineshaw HM; Zettler CM; Prescott J; Garg M; Chakraborty S; Sarpong EM; Bai C; Belli AJ; Fernandes LL; Wang CK
Cancer Med; 2024 Apr; 13(7):e7173. PubMed ID: 38597118
[TBL] [Abstract] [Full Text] [Related]
11. Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Watanabe T; Matsuno Y; Wakabayashi M; Maruyama D; Yamamoto K; Kubota N; Shimada K; Asagoe K; Yamaguchi M; Ando K; Ogura M; Kuroda J; Suehiro Y; Tsukasaki K; Tobinai K; Nagai H
Hematol Oncol; 2024 May; 42(3):e3272. PubMed ID: 38595316
[TBL] [Abstract] [Full Text] [Related]
12. Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy.
McQuilten ZK; Weinkove R; Thao LTP; Crispin P; Degelia A; Dendle C; Gilbertson M; Johnston A; Keegan A; Pepperell D; Pullon H; Reynolds J; van Tonder T; Trotman J; Waters N; Wellard C; Weston H; Morrissey CO; Wood EM
Blood Adv; 2024 Apr; 8(7):1787-1795. PubMed ID: 38592710
[TBL] [Abstract] [Full Text] [Related]
13. Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.
Chen MF; Song Z; Yu HA; Sequist LV; Lovly CM; Mitchell EP; Moscow JA; Gray RJ; Wang V; McShane LM; Rubinstein LV; Patton DR; Williams PM; Hamilton SR; Umemura Y; Tricoli JV; Conley BA; Arteaga CL; Harris LN; O'Dwyer PJ; Chen AP; Flaherty KT
JCO Precis Oncol; 2024 Apr; 8():e2300454. PubMed ID: 38591867
[TBL] [Abstract] [Full Text] [Related]
14. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma.
Draye-Carbonnier S; Camus V; Becker S; Tonnelet D; Lévêque E; Zduniak A; Jardin F; Tilly H; Vera P; Decazes P
Sci Rep; 2024 Apr; 14(1):8033. PubMed ID: 38580734
[TBL] [Abstract] [Full Text] [Related]
16. Neuropsychological task outcomes among survivors of childhood acute lymphoblastic leukemia in Malaysia.
Alias H; Mohd Ranai N; Lau SCD; de Sonneville LMJ
Sci Rep; 2024 Apr; 14(1):7915. PubMed ID: 38575744
[TBL] [Abstract] [Full Text] [Related]
17. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
Li J; Ma X; Xu F; Yan Y; Chen W
Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
[TBL] [Abstract] [Full Text] [Related]
18. Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy.
Fang HW; Tseng PL; Hu TH; Wang JH; Hung CH; Lu SN; Chen CH
Virol J; 2024 Apr; 21(1):79. PubMed ID: 38570803
[TBL] [Abstract] [Full Text] [Related]
19. Declining incidence and improving survival of ocular and orbital lymphomas in the US between 1995 and 2018.
Alfaar AS; Yousef YA; W Wilson M; Hassanain O; Kakkassery V; Moustafa M; Kunbaz A; Esmael A; Strauß O
Sci Rep; 2024 Apr; 14(1):7886. PubMed ID: 38570585
[TBL] [Abstract] [Full Text] [Related]
20. Clinical features of intussusception in children secondary to small bowel tumours: a retrospective study of 31 cases.
Wang L; Zhang H; Wang D; Shen Q; Huang L; Liu T
BMC Pediatr; 2024 Apr; 24(1):227. PubMed ID: 38561715
[TBL] [Abstract] [Full Text] [Related]
[Next]
